BioMimetic Therapeutics AUGMENT Kit Recall: Wrong Vial Tray Hazard
BioMimetic Therapeutics recalls AUGMENT Injectable Kit (Model K30003010, Lot 1706343) due to incorrect vial tray packaging. This may cause improper use during injections.
Lower-risk recall
The kit contains the wrong vial tray in the package.
Contact the company
What happened, in plain English
BioMimetic Therapeutics is recalling their AUGMENT Injectable Kit (Model K30003010, Lot 1706343) because it contains the wrong vial tray. This could lead to improper injection technique if the kit is used without the correct tray. Read more at govinfonow.com/recall/62163-biomimetic-therapeutics-augment-kit-recall-wrong-vial-tray-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/62163-biomimetic-therapeutics-augment-kit-recall-wrong-vial-tray-hazard · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2335-2021
Cite this page
“BioMimetic Therapeutics AUGMENT Kit Recall: Wrong Vial Tray Hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/62163-biomimetic-therapeutics-augment-kit-recall-wrong-vial-tray-hazard. Based on FDA recall #Z-2335-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2335-2021%22&limit=1).
Why it’s dangerous
The kit includes an incorrect vial tray, which could cause improper injection technique. This might lead to incorrect dosing or ineffective treatment if the user is not using the correct tray.
Who’s affected
Users of the AUGMENT Injectable Kit (Model K30003010, Lot 1706343) who are administering injections. Those with medical conditions requiring precise injection techniques may be at slightly higher risk.
How to tell if you have this one
Check for the model number K30003010 and lot number 1706343 on the packaging. The recall applies to the AUGMENT Injectable Kit, 3cc, sold by BioMimetic Therapeutics.
- Brand
BioMimetic Therapeutics- Category
Medical device
What to do — step by step
Check Package Details
Verify the model number K30003010 and lot number 1706343 on the packaging to confirm if the kit is affected.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 24 states.
FDA distribution: “US Nationwide distribution in the states of AK, CA, CO, FL, GA, IA, ID, IL, IN, MA, MI, MN, NC, NJ, NM, NY, OH, OR, PA, TX, UT, VA, WA, and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alaska, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia, Washington, Wisconsin.
Recall timeline
FDA terminated this recall 3.1 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this recall dangerous?
The recall is for a packaging issue that could lead to improper injection technique, but it does not pose a risk of serious injury or death.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2335-2021 (July 23, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2335-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.